![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BMP2K mRNA] | CTD | PMID:31150632 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | BMP2K (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BMP2K mRNA | CTD | PMID:22079256 | 1,2-dichloroethane | decreases expression | ISO | Bmp2k (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of BMP2K mRNA | CTD | PMID:28960355 | 17alpha-ethynylestradiol | multiple interactions | ISO | Bmp2k (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BMP2K mRNA | CTD | PMID:17942748 | 17beta-estradiol | increases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Estradiol results in increased expression of BMP2K mRNA | CTD | PMID:31614463 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | BMP2K (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:19095052 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Bmp2k (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Bmp2k (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BMP2K mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BMP2K mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Bmp2k (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of BMP2K mRNA | CTD | PMID:21570461 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | BMP2K (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BMP2K mRNA | CTD | PMID:28628672 | 4,4'-diaminodiphenylmethane | increases expression | ISO | Bmp2k (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of BMP2K mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Bmp2k (Mus musculus) | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased methylation of BMP2K exon | CTD | PMID:33297965 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Bmp2k (Mus musculus) | 6480464 | Fenretinide results in decreased expression of BMP2K mRNA | CTD | PMID:28973697 | aflatoxin B1 | decreases methylation | ISO | BMP2K (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of BMP2K gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Tretinoin results in increased expression of BMP2K mRNA | CTD | PMID:33167477 | amiodarone | increases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Amiodarone results in increased expression of BMP2K mRNA | CTD | PMID:19774075 | antirheumatic drug | decreases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of BMP2K mRNA | CTD | PMID:24449571 | benzo[a]pyrene | decreases expression | ISO | Bmp2k (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of BMP2K mRNA | CTD | PMID:19770486 | benzo[a]pyrene | affects methylation | ISO | BMP2K (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of BMP2K intron | CTD | PMID:30157460 | benzo[a]pyrene | decreases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of BMP2K mRNA | CTD | PMID:20064835 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | BMP2K (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of BMP2K mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | BMP2K (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of BMP2K gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of BMP2K mRNA | CTD | PMID:30816183 | bisphenol F | multiple interactions | ISO | BMP2K (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BMP2K mRNA | CTD | PMID:28628672 | cadmium atom | multiple interactions | ISO | BMP2K (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BMP2K mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | BMP2K (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BMP2K mRNA | CTD | PMID:35301059 | caffeine | decreases phosphorylation | ISO | BMP2K (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of BMP2K protein | CTD | PMID:35688186 | carbamazepine | affects expression | ISO | BMP2K (Homo sapiens) | 6480464 | Carbamazepine affects the expression of BMP2K mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | Bmp2k (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | cisplatin | multiple interactions | ISO | BMP2K (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of BMP2K mRNA | CTD | PMID:27392435 | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of BMP2K mRNA | CTD | PMID:20187946 | coumarin | decreases phosphorylation | ISO | BMP2K (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of BMP2K protein | CTD | PMID:35688186 | cyclosporin A | decreases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of BMP2K mRNA | CTD | PMID:27989131 | dexamethasone | multiple interactions | ISO | BMP2K (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BMP2K mRNA | CTD | PMID:28628672 | ethanol | increases expression | ISO | Bmp2k (Mus musculus) | 6480464 | Ethanol results in increased expression of BMP2K mRNA | CTD | PMID:30319688 | fluoranthene | multiple interactions | ISO | Bmp2k (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of BMP2K mRNA | CTD | PMID:28329830 | folic acid | decreases expression | ISO | Bmp2k (Mus musculus) | 6480464 | Folic Acid results in decreased expression of BMP2K mRNA | CTD | PMID:25629700 | formaldehyde | increases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of BMP2K mRNA | CTD | PMID:23649840 | gallic acid | increases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Gallic Acid results in increased expression of BMP2K mRNA | CTD | PMID:34408198 | genistein | increases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Genistein results in increased expression of BMP2K mRNA | CTD | PMID:26865667 | genistein | decreases expression | ISO | Bmp2k (Mus musculus) | 6480464 | Genistein results in decreased expression of BMP2K mRNA | CTD | PMID:32186404 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of BMP2K mRNA | CTD | PMID:33387578 | glycidyl methacrylate | increases expression | ISO | BMP2K (Homo sapiens) | 6480464 | glycidyl methacrylate results in increased expression of BMP2K protein | CTD | PMID:36641056 | indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BMP2K mRNA | CTD | PMID:22129741 | indometacin | decreases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Indomethacin results in decreased expression of BMP2K mRNA | CTD | PMID:16984733 | indometacin | multiple interactions | ISO | BMP2K (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BMP2K mRNA | CTD | PMID:28628672 | ivermectin | increases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Ivermectin results in increased expression of BMP2K protein | CTD | PMID:32959892 | lipopolysaccharide | multiple interactions | ISO | BMP2K (Homo sapiens) | 6480464 | [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of BMP2K mRNA | CTD | PMID:26667767 | methotrexate | affects expression | ISO | Bmp2k (Mus musculus) | 6480464 | Methotrexate affects the expression of BMP2K mRNA | CTD | PMID:18502557 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of BMP2K gene | CTD | PMID:35440735 | methylmercury chloride | decreases expression | ISO | BMP2K (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of BMP2K mRNA | CTD | PMID:28001369 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BMP2K mRNA | CTD | PMID:22129741 | nickel atom | decreases expression | ISO | Bmp2k (Mus musculus) | 6480464 | Nickel results in decreased expression of BMP2K mRNA | CTD | PMID:12540486 | paracetamol | affects expression | ISO | Bmp2k (Mus musculus) | 6480464 | Acetaminophen affects the expression of BMP2K mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of BMP2K mRNA | CTD | PMID:33387578 | phenobarbital | affects expression | ISO | Bmp2k (Mus musculus) | 6480464 | Phenobarbital affects the expression of BMP2K mRNA | CTD | PMID:23091169 | pirinixic acid | multiple interactions | ISO | BMP2K (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of BMP2K mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | Bmp2k (Mus musculus) | 6480464 | pirinixic acid results in increased expression of BMP2K mRNA | CTD | PMID:18445702 | piroxicam | increases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Piroxicam results in increased expression of BMP2K mRNA | CTD | PMID:21858171 | potassium chromate | decreases expression | ISO | BMP2K (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of BMP2K mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | BMP2K (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BMP2K mRNA | CTD | PMID:22079256 | quercetin | affects expression | ISO | BMP2K (Homo sapiens) | 6480464 | Quercetin affects the expression of BMP2K mRNA | CTD | PMID:21632981 | quinolin-8-ol | decreases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Oxyquinoline results in decreased expression of BMP2K mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | BMP2K (Homo sapiens) | 6480464 | [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of BMP2K mRNA and [Plant Extracts co-treated with Resveratrol] results in increased expression of BMP2K mRNA | CTD | PMID:23557933 and PMID:26667767 | sunitinib | increases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Sunitinib results in increased expression of BMP2K mRNA | CTD | PMID:31533062 | tamoxifen | affects expression | ISO | BMP2K (Homo sapiens) | 6480464 | Tamoxifen affects the expression of BMP2K mRNA | CTD | PMID:14699072 | tamoxifen | decreases expression | ISO | Bmp2k (Mus musculus) | 6480464 | Tamoxifen results in decreased expression of BMP2K mRNA | CTD | PMID:17555576 | testosterone enanthate | affects expression | ISO | BMP2K (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of BMP2K mRNA | CTD | PMID:17440010 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BMP2K mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of BMP2K mRNA | CTD | PMID:31150632 | thapsigargin | decreases expression | ISO | Bmp2k (Mus musculus) | 6480464 | Thapsigargin results in decreased expression of BMP2K protein | CTD | PMID:24648495 | thimerosal | increases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Thimerosal results in increased expression of BMP2K mRNA | CTD | PMID:27188386 | titanium dioxide | increases expression | ISO | Bmp2k (Mus musculus) | 6480464 | titanium dioxide results in increased expression of BMP2K mRNA | CTD | PMID:23557971 | titanium dioxide | decreases expression | ISO | Bmp2k (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of BMP2K mRNA | CTD | PMID:29264374 | triclosan | decreases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Triclosan results in decreased expression of BMP2K mRNA | CTD | PMID:30510588 | valproic acid | decreases methylation | ISO | BMP2K (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of BMP2K gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of BMP2K mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | BMP2K (Homo sapiens) | 6480464 | Valproic Acid affects the expression of BMP2K mRNA | CTD | PMID:25979313 | vitamin E | decreases expression | ISO | BMP2K (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of BMP2K mRNA | CTD | PMID:19244175 | |